文献速递新生儿

经皮胆红素测定在黄疸新生儿中的随机对照试验

Transcutaneous Bilirubinometry in Jaundiced Neonates: A Randomized Controlled Trial.
PubMed 文献 · Pediatrics · 2016-11-04

这项随机对照试验纳入430例胎龄≥32周的住院黄疸新生儿,比较经皮胆红素测定(TcB)指导与视觉临床评估指导采血的效果。TcB组至少采血一次的比例为48.4%,对照组为79.3%(差异30.5%,95%CI 21.5-38.7,P<.001),采血次数减少38.5%。两组胆红素峰值、光疗或换血指征及住院时长无差异。

要点

  • TcB指导可减少黄疸新生儿采血次数超过三分之一。
  • TcB组至少一次采血比例48.4%,低于对照组的79.3%。
  • 两组胆红素峰值、光疗或换血指征及住院时长无差异。

核心结论

  • 在黄疸新生儿中使用TcB可行且安全,可使采血次数减少超过三分之一。

研究设计与样本

  • 随机对照试验,纳入胎龄≥32周的住院黄疸新生儿430例,TcB组213例,对照组217例,采用意向性分析。

主要发现

  • TcB组至少采血一次的比例为48.4%,对照组为79.3%,差异30.5%(95%CI 21.5-38.7,P<.001)。
  • 采血次数显著减少38.5%(0.9±1.1 vs 1.3±1.0,差异-0.5,95%CI -0.7至-0.3,P<.001)。
  • 两组胆红素峰值、光疗或换血指征及住院时长无差异。

关键数值与推荐

  • 当TcB低于光疗阈值50 µmol/L时,才采血检测血清胆红素(SB)。
  • 开始治疗的决定始终基于SB值。

临床怎么用

  • 对胎龄≥32周的住院黄疸新生儿,可用TcB指导采血决策以减少血样采集。
  • 当TcB低于光疗阈值50 µmol/L时再采血测SB,治疗决策仍以SB为准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For evaluation of jaundiced neonates, serum bilirubin (SB) or transcutaneous bilirubinometry (TcB) is used. Few data are available on the quantitative reduction of blood sampling by using TcB. METHODS: We conducted a randomized controlled trial in hospitalized jaundiced neonates ≥32 weeks' gestational age. In the intervention group, TcB was used and in the control group the decision to obtain a blood sample for SB was based on visual and clinical assessment. Outcome measure was the number of blood samples before phototherapy. When TcB was <50 µmol/L below the threshold for phototherapy, SB was obtained. The decision to start treatment was always based on an SB value. RESULTS: A total of 430 were randomized and included in the intention-to-treat analysis: 213 in the TcB group and 217 in the control group. In the TcB group, 104 (48.4%) had at least 1 blood sample taken for SB, versus 172 (79.3%) in the control group (difference 30.5%, 95% confidence interval 21.5-38.7, P < .001). The number of blood draws was significantly reduced by 38.5% (0.9 ± 1.1 vs 1.3 ± 1.0, difference -0.5, 95% confidence interval -0.7 to -0.3, P < .001). Peak of bilirubin value, indications for phototherapy, or exchange transfusion and hospitalization length were not different between groups. CONCLUSIONS: The use of TcB in jaundiced neonates is feasible and safe, resulting in a reduction of more than one-third in blood draws.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. van den Esker-Jonker B, den Boer L, Pepping RM, et al. Transcutaneous Bilirubinometry in Jaundiced Neonates: A Randomized Controlled Trial. Pediatrics. 2016. PMID: 27940715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。